Literature DB >> 24212775

Role of Surgery in Stages II and III Pediatric Abdominal Non-Hodgkin Lymphoma: A 5-Years Experience.

Amany M Ali1, Heba A Sayd, Hesham M Hamza, Mohamed A Salem.   

Abstract

Abdominal Non-Hodgkin lymphomas (NHL) are the most common extra nodal presentation of pediatric NHL. Our aim is to assess the role of surgery as a risk factor and to evaluate the impact of risk-adjusted systemic chemotherapy on survival of patients with stages II and III disease. This study included 35 pediatric patients with abdominal NHL treated over five years at South Egypt Cancer Institute (SECI), Assiut University, between January 2005 and January 2010. The data of every patient included: Age, sex, and presentation, staging work up to determine extent of the disease and the type of resection performed, histopathological examination, details of chemotherapy, disease free survival and overall survival. The study included 25 boys and 10 girls with a median age of six years (range: 2.5:15). Thirty patients (86%) presented with abdominal pain, 23 patients (66%) presented with abdominal mass and distention, 13 patients (34%) presented with weight loss, and intestinal obstruction occurred in six patients (17%). The ileo-cecal region and abdominal lymph nodes were the commonest sites (48.5%, 21% respectively). Burkitt's lymphoma was the most common histological type in 29 patients (83%). Ten (28.5%) stage II (group A) and 25 (71.5%) stage III (group B). Complete resections were performed in 10 (28.5%), debulking in 6 (17%) and imaging guided biopsy in 19 (54%). A11 patients received systemic chemotherapy. The median follow up duration was 63 months (range 51-78 months). The parameters that significantly affect the overall survival were stage at presentation complete resection for localized disease. In conclusion, the extent of disease at presentation is the most important prognostic factor in pediatric abdominal NHL. Surgery is restricted to defined situations such as; abdominal emergencies, diagnostic biopsy and total tumor extirpation in localized disease. Chemotherapy is the cornerstone in the management of pediatric abdominal NHL.

Entities:  

Year:  2011        PMID: 24212775      PMCID: PMC3757380          DOI: 10.3390/cancers3021593

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  11 in total

1.  Pediatric non-Hodgkin lymphomas in children: diagnosis and current management.

Authors:  T S Vats
Journal:  Indian Pediatr       Date:  2001-06       Impact factor: 1.411

2.  Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study.

Authors:  Ivo Radman; Jasminka Kovacević-Metelko; Igor Aurer; Damir Nemet; Silva Zupancić-Salek; Vinko Bogdanić; Dubravka Sertić; Mirando Mrsić; Roland Pulanić; Vladimir Gasparović; Boris Labar
Journal:  Croat Med J       Date:  2002-10       Impact factor: 1.351

3.  Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution.

Authors:  S B Murphy; D L Fairclough; R E Hutchison; C W Berard
Journal:  J Clin Oncol       Date:  1989-02       Impact factor: 44.544

Review 4.  Non-Hodgkin's lymphoma in childhood.

Authors:  J T Sandlund; J R Downing; W M Crist
Journal:  N Engl J Med       Date:  1996-05-09       Impact factor: 91.245

5.  Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

Authors:  A Reiter; M Schrappe; M Tiemann; W D Ludwig; E Yakisan; M Zimmermann; G Mann; A Chott; W Ebell; T Klingebiel; N Graf; B Kremens; S Müller-Weihrich; H J Plüss; F Zintl; G Henze; H Riehm
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

6.  Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group.

Authors:  D Wright; P McKeever; R Carter
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

7.  The role of surgery in abdominal non-Hodgkin's lymphoma: experience from the Childrens Cancer Study Group.

Authors:  M P LaQuaglia; C J Stolar; M Krailo; P Exelby; S Siegel; A Meadows; D Hammond
Journal:  J Pediatr Surg       Date:  1992-02       Impact factor: 2.545

8.  The role of surgery in the treatment of pediatric B-cell non-Hodgkin's lymphoma.

Authors:  Andishe Attarbaschi; Georg Mann; Michael Dworzak; Monika Trebo; Nora Mühlegger; Alfred Reiter; Ernst Horcher; Helmut Gadner
Journal:  J Pediatr Surg       Date:  2002-10       Impact factor: 2.545

9.  Improved outcome in childhood B-cell lymphoma with the intensified French LMB protocol.

Authors:  I Yaniv; S Fischer; C Mor; B Stark; Y Goshen; J Stein; I J Cohen; R Zaizov
Journal:  Med Pediatr Oncol       Date:  2000-07

10.  Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.

Authors:  A Atra; J D Imeson; R Hobson; M Gerrard; I M Hann; O B Eden; R L Carter; C R Pinkerton
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

View more
  1 in total

1.  Clinicopathological Study of Primary Pediatric Gastrointestinal Lymphomas.

Authors:  Moupali Ghosh; Moumita Sengupta; Shibsankar Barman; Uttara Chatterjee; Madhumita Mukhopadhyay; Ruchirendu Sarkar; Koushik Saha; Ashoke Kumar Basu
Journal:  J Indian Assoc Pediatr Surg       Date:  2021-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.